TOP特許意匠商標
商標ウォッチ Twitter
公開日2025-05-21
公報種別公開国際商標公報
国際登録番号1845424
国際登録日2024-12-18
区分第1類(化学品),第5類(薬剤),第42類(科学・技術)
商品役務Chemical preparations for scientific and industrial purposes; genetically engineered polypeptides and proteins, in particular antibodies and antibody-like polypeptides and proteins, and nucleic acid coding for these, in particular artificial polypeptides and proteins and nucleic acid coding for these; diagnostic preparations, except for medical or veterinary use.,Pharmaceuticals, medical and veterinary preparations; pharmaceutical preparations and formulations and medicinal health preparations for use in the treatment or prevention of diseases, ailments and/or disorders in humans and/or animals, in particular circulatory, respiratory, endocrine, neurological, cardiovascular, nutritional, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, ailments and/or disorders and the treatment or prevention of complications associated with such diseases全 96 件を表示, ailments and/or disorders; pharmaceutical preparations and formulations and medicinal health preparations for use in the treatment or prevention of illnesses, ailments and/or disorders in humans and/or animals, in particular bone, sensory organ, viral, urinary tract, kidney, metabolic or central nervous system diseases, complaints and/or disorders and the treatment or prevention of complications associated with such diseases, ailments and/or disorders; pharmaceutical preparations and formulations and medicinal health preparations for use in the treatment or prevention of diseases, ailments and/or disorders in humans and/or animals, in particular infectious, autoimmune or immunological, cell proliferative and/or oncological diseases, ailments and/or disorders, cancers, tumours and metastases and the treatment or prevention of complications associated with such diseases, ailments and/or disorders; pharmaceutical preparations and formulations and medical health preparations, in particular artificial polypeptides and proteins, in particular antibodies and antibody-like polypeptides and proteins, and nucleic acid coding for these, in particular for use in the following areas: treatment or prevention of various types of cancer, inflammatory diseases and autoimmune diseases; diagnostic preparations and biomarker reagents for medical or veterinary purposes; diagnostic preparations and diagnostic biomarker reagents for the diagnosis and/or prognosis of human and/or animal diseases, ailments and/or disorders, in particular circulatory, respiratory, endocrine, neurological, cardiovascular, nutritional, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, ailments and/or disorders and the diagnosis and/or prognosis in relation to complications associated with such diseases, ailments and/or disorders; diagnostic preparations and diagnostic biomarker reagents for the diagnosis and/or prognosis of human and/or animal diseases, ailments and/or disorders, in particular bone, sensory organ, virus, urinary tract, kidney, metabolic or central nervous system diseases, ailments and/or disorders and the diagnosis and/or prognosis in relation to complications associated with such diseases, ailments and/or disorders; diagnostic preparations and diagnostic biomarker reagents for the diagnosis and/or prognosis of diseases, ailments and/or disorders in humans and/or animals, in particular infectious, autoimmune or immunological, cell proliferative and/or oncological diseases, ailments and/or disorders, cancers, tumours and metastases and the diagnosis and/or prognosis in relation to complications associated with such diseases, ailments and/or disorders.,Scientific services and research relating thereto; scientific services and research relating to biology, chemistry or medicine, as well as immunology, oncology, molecular biology, cell biology, biochemistry and/or medicinal chemistry, and relating to the discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic agents and diagnostic biomarker reagents and/or diagnostic apparatus; conducting evaluations in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of platform technology, namely a cancer immunotherapy platform for the production of therapeutics; chemical, biological and biochemical laboratory services; conducting chemical, biochemical and biological analyses; cancer diagnostics for scientific purposes; services of a biological or biochemical laboratory; biological and biochemical examination services; providing technical and scientific information about a biotechnology company, its technologies, projects, product-candidates, products and/or services via a web site on a global computer network; software design and development; design and development of computer software for use in the fields of biology, chemistry or medicine, in particular immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry, as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents and/or diagnostic apparatus.
基礎出願番号019065956
基礎出願日2024-08-09
基礎出願国EM
出願人iOmx Therapeutics AG
OCRテキストIOMX
OCRテキスト2IOMX
OCRについて
この商標をJ-PlatPatで参照する

関連商標

個人
Klüber
10日前
Lydian Labs, Inc.
1か月前
MEGGLE Group GmbH
17日前
INTEGRATED GRAPHENE LIMITED
❤iGiiiGii
17日前
Velocys Technologies Limited
SQRCAT
17日前
個人
ADULARIA
17日前
Croda International Plc
10日前
Terrana Biosciences, Inc.
10日前
Terrana Biosciences, Inc.
10日前
Rockfish Bio AG
చి ROCKFISH BIO
17日前
Danstar Ferment AG
10日前
NAOLYS
10日前
Lyten, Inc.
10日前
Lycored Ltd.
10日前
Beijing KansenBio Technologies Co., Ltd
10日前
COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
10日前
Givaudan SA
LIPAFRESH
17日前
VIVATIS Pharma GmbH
3日前
MONTELOEDER, S.L.
10日前
個人
17日前
Croda International Plc
17日前
Spigen Korea Co., Ltd.
17日前
Hoosier Racing Tire Corp.
H HOOSIER
17日前
QIAGEN GmbH
QIAwave
17日前
Evonik Operations GmbH
OCTAMAX
17日前
Croda International Plc
CRODA
17日前
Suzhou Fushilai Pharmaceutical Co., Ltd.
17日前
LABORATOIRES EXPANSCIENCE
TULSINITY
17日前
Wuhan Hzymes Biotechnology Co., Ltd.
17日前
Nanjing Genvivo Biotech Co., Ltd.
17日前
Life Technologies Corporation
17日前
Fujian Yuanxiang New Materials Co., Ltd.
17日前
Nordic Bioproducts Group Oy
PuraSeries
24日前
SEDERMA
ZENAKINE
10日前
Wanhua Chemical Group Co., Ltd.
GWANHUA
10日前
BALSU GIDA SANAYI VE TICARET ANONIM SIRKETI
HENDEX
24日前
続きを見る